MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 25 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,333,000 | -30.0% | 2,976,121 | 0.0% | 0.07% | -5.4% |
| Q4 2021 | $4,762,000 | -33.9% | 2,976,121 | 0.0% | 0.07% | -21.3% |
| Q3 2021 | $7,202,000 | -23.7% | 2,976,121 | 0.0% | 0.09% | -3.1% |
| Q2 2021 | $9,434,000 | -5.9% | 2,976,121 | 0.0% | 0.10% | -2.0% |
| Q1 2021 | $10,030,000 | -5.9% | 2,976,121 | 0.0% | 0.10% | +16.5% |
| Q4 2020 | $10,655,000 | +154.5% | 2,976,121 | +86.2% | 0.08% | +165.6% |
| Q3 2020 | $4,187,000 | +996.1% | 1,598,185 | +1178.9% | 0.03% | +966.7% |
| Q2 2020 | $382,000 | – | 124,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |